A newly posted page about psilocybin on a federal health agency’s website acknowledges the potential benefits the psychedelic substance might provide—including for treatment of alcohol use disorder, anxiety and depression. The page also highlights psilocybin research being funded by the federal government into the drug’s effects on pain, migraines, psychiatric disorders and various other conditions. … Continue reading Federal Health Agency Acknowledges Psilocybin’s Therapeutic Potential And Touts Forthcoming Psychedelic Research